IRTC iRhythm Holdings, Inc.

company

SEC Filings & Insider Trading Activity 2026

Risk Factors

• • No specific regulatory or legal risk disclosed in the risk factors section
• • No geopolitical or macroeconomic threat with concrete exposure detailed
• • Operational risk: dependency on Nasdaq Global Select Market listing under symbol "IRTC" for liquidity and capital access
• • Competitive risk: no named competitor or technology disruption identified in provided text
• • Financial risk: no dividends declared, retaining all funds to finance growth, no issuer repurchases

Business Overview

• • Core business model: Design, development, and commercialization of long-term continuous ambulatory cardiac monitoring (ACM) services using patch-based ECG biosensors with proprietary AI analytics
• • New product emphasis: Introduction of smaller, lighter Zio monitor System with Bluetooth and breathable adhesive, enhancing patient compliance and data quality vs prior Zio XT
• • Strategic shift: Expanding ACM adoption beyond cardiology into primary care and integrated delivery networks to capture earlier-stage patient populations with undiagnosed arrhythmias
• • Quantitative highlights: ~2,400 employees as of Dec 31, 2025; ~40% penetration of core U.S. ambulatory cardiac monitoring market; over 12 million patient reports generated
• • Noteworthy fact: Clinical studies (CAMELOT and AVALON) covering >700,000 diagnostic-naive patients demonstrate Zio LTCM Service’s highest diagnostic yield and lower costly hospitalizations than competitors

Management Discussion & Analysis

• • Revenue $747.1M, up 26% YoY from $591.8M driven by volume increases and new Zio AT customer growth
• • Operating margin -8% in 2025 vs -20% in 2024, loss from operations improved by $58.1M to ($57.4M)
• • Best performing segment: iRhythm Services volume growth with significant Zio AT revenue increase; no specific segment dollar detailed for worst performance
• • Cash flow from operations $80.9M vs $3.4M YoY; invested $277.1M in investing activities including $347.9M marketable securities purchases; financed with $12.6M cash from financing activities, down from $511.4M in 2024
• • Management notes macroeconomic uncertainty, higher contractual allowance reserves due to payer claim denials, expects liquidity sufficiency for 12 months, terminated Verily collaboration to focus on clinical-grade wearables

What are the latest IRTC SEC filings in 2026?

iRhythm Holdings, Inc. (IRTC) has filed a 10-K annual report on February 19, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on June 15, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did IRTC file its most recent 10-K annual report?

iRhythm Holdings, Inc. (IRTC) filed its most recent 10-K annual report on February 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view IRTC 10-Q quarterly reports?

iRhythm Holdings, Inc. (IRTC)'s most recent 10-Q quarterly report was filed on April 30, 2026. SignalX displays every IRTC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has IRTC filed recently?

iRhythm Holdings, Inc. (IRTC)'s most recent 8-K was filed on June 15, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find IRTC insider trading activity (Form 4)?

SignalX aggregates every IRTC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does IRTC file with the SEC?

iRhythm Holdings, Inc. (IRTC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new IRTC filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for iRhythm Holdings, Inc. (IRTC).

What is IRTC's SEC CIK number?

iRhythm Holdings, Inc. (IRTC)'s SEC CIK (Central Index Key) number is 1388658. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1388658 to look up all IRTC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find IRTC return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from iRhythm Holdings, Inc. (IRTC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.